Skip to main content
Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
1.030
+0.030 (3.00%)
At close: May 31, 2024, 4:00 PM
1.010
-0.020 (-1.94%)
After-hours: May 31, 2024, 6:44 PM EDT

Biofrontera Revenue

Biofrontera had revenue of $33.25M in the twelve months ending March 31, 2024, with 20.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.91M, a -9.40% decrease year-over-year. In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth.

Revenue (ttm)
$33.25M
Revenue Growth
+20.23%
P/S Ratio
0.16
Revenue / Employee
$400,627
Employees
83
Market Cap
5.24M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
iSpecimen 9.27M
Akanda 2.16M
Soligenix 699.21K
Azitra 572.70K
Nexalin Technology 158.86K
Ainos -28.44K
Revenue Rankings

BFRI News

More News